Literature DB >> 12554354

Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils.

Ruedi K Braun1, Martin Foerster, Grefachew Workalemahu, Daniela Haefner, Claus Kroegel, Christoph Walker.   

Abstract

Aminopeptidase N (CD13) is a cell surface metalloprotease involved in growth regulation, tumor invasion, and down-regulation of regulatory peptides. CD13 expression on eosinophils in bronchoalveolar lavage (BAL) of asthmatics 10 minutes and 18 hours after segmental allergen provocation was significantly increased (+225% to +294%) compared to blood eosinophils. In vitro CD13 expression could be induced on blood eosinophils by transendothelial migration of the cells across interlenkin (IL) 1beta-activated human umbilical cord vein endothelial cells (HUVECs) as well as by the exposure to the cytokines IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF). The cytokines GM-CSF and IL-5 were significantly less effective in inducing CD13 compared to IL-3. The IL-3-induced expression of CD13 was decreased in the presence of the protein-synthesis inhibitor cycloheximide (-8.8%). Moreover, blocking of CD13 by the protease inhibitors actinonin and bestatin significantly enhanced migration (+40.0% to +80.0%) of eosinophils across HUVEC monolayers. In summary, the data suggest that CD13 is regulated both by the process of transmigration and by the cytokine IL-3. Further, CD13 itself seems to be involved in the process of eosinophil transmigration. aminopeptidase Nendothelial cellseosinophilsinterleukin-3interleukin-5transendothelial migration

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554354     DOI: 10.1080/01902140303766

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  7 in total

1.  Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.

Authors:  Roopa Jones Ganji; Ravikumar Reddi; Rajesh Gumpena; Anil Kumar Marapaka; Tarun Arya; Priyanka Sankoju; Supriya Bhukya; Anthony Addlagatta
Journal:  Protein Sci       Date:  2015-04-08       Impact factor: 6.725

Review 2.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

3.  IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.

Authors:  S Esnault; M W Johansson; E A Kelly; L Koenderman; D F Mosher; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2017-01-23       Impact factor: 5.018

Review 4.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 5.  Eosinophil Activation Status in Separate Compartments and Association with Asthma.

Authors:  Mats W Johansson
Journal:  Front Med (Lausanne)       Date:  2017-06-12

Review 6.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

Review 7.  Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease.

Authors:  Samuel N Uwaezuoke; Adaeze C Ayuk; Joy N Eze
Journal:  J Asthma Allergy       Date:  2018-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.